Found: 58
Select item for more details and to access through your institution.
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01088-6
- By:
- Publication type:
- Article
Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 111, doi. 10.3390/ijms24010111
- By:
- Publication type:
- Article
Future Directions in Maintenance Therapy in Multiple Myeloma.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 11, p. 2261, doi. 10.3390/jcm10112261
- By:
- Publication type:
- Article
Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2227, doi. 10.1111/bjh.19386
- By:
- Publication type:
- Article
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 3, p. 355, doi. 10.1111/bjh.18432
- By:
- Publication type:
- Article
Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 783, doi. 10.1111/bjh.14483
- By:
- Publication type:
- Article
Preclinical investigation of a potent geranylgeranyl diphosphate synthase inhibitor.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 810, doi. 10.1007/s10637-018-0571-3
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 594, doi. 10.1007/s10637-015-0220-z
- By:
- Publication type:
- Article
Health‐related quality of life in transplant‐eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient‐reported outcomes from GRIFFIN.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1257, doi. 10.1002/ajh.27326
- By:
- Publication type:
- Article
Evolution of Treatment Paradigms in Newly Diagnosed Multiple Myeloma.
- Published in:
- Drugs, 2021, v. 81, n. 7, p. 825, doi. 10.1007/s40265-021-01514-0
- By:
- Publication type:
- Article
Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience.
- Published in:
- Drugs, 2017, v. 77, n. 5, p. 505, doi. 10.1007/s40265-017-0689-1
- By:
- Publication type:
- Article
The Role of Osteocytes in Targeted Bone Remodeling: A Mathematical Model
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063884
- By:
- Publication type:
- Article
Synchronous presentation of monoclonal gammopathy and Fabry nephropathy; diagnostic renal biopsy obviates initiation of myeloma therapy.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Current Frontline Treatment of Multiple Myeloma.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 7, p. 430
- By:
- Publication type:
- Article
Treatment Considerations for Transplant-Ineligible Multiple Myeloma.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 170
- By:
- Publication type:
- Article
Development and Validation of an LC-MS/MS Assay for the Quantitation of MO-OH-Nap Tropolone in Mouse Plasma: Application to In Vitro and In Vivo Pharmacokinetic Studies.
- Published in:
- Molecules, 2024, v. 29, n. 18, p. 4424, doi. 10.3390/molecules29184424
- By:
- Publication type:
- Article
Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 1, p. 1, doi. 10.1002/ctm2.1167
- By:
- Publication type:
- Article
Update on the role of lenalidomide in patients with multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 7, p. 175, doi. 10.1177/2040620718775629
- By:
- Publication type:
- Article
Naloxone does not attenuate the locomotor effects of ethanol in FAST, SLOW, or two heterogeneous stocks of mice.
- Published in:
- Psychopharmacology, 2005, v. 182, n. 2, p. 277, doi. 10.1007/s00213-005-0066-8
- By:
- Publication type:
- Article
P-180: Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in newly diagnosed Multiple Myeloma (NDMM): analysis of vascular thrombotic events (VTEs) in the GRIFFIN study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S135, doi. 10.1016/S2152-2650(21)02307-7
- By:
- Publication type:
- Article
Survival of Older Adults With Newly Diagnosed Acute Myeloid Leukemia: Effect of Using Multiagent Versus Single-agent Chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Preclinical evaluation of tropolone and proteasome inhibitor therapy for multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e130, doi. 10.1016/j.clml.2019.09.216
- By:
- Publication type:
- Article
A Phase I study of PNK-007, allogeneic, off the shelf NK cell, post autologous transplant in multiple myeloma (NCT02955550).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e112, doi. 10.1016/j.clml.2019.09.187
- By:
- Publication type:
- Article
Lenalidomide (LEN) Maintenance Following High-Dose Melphalan and Autologous Stem Cell Transplant (ASCT) in Patients (Pts) With Newly Diagnosed Multiple Myeloma (MM): A Meta-Analysis of Overall Survival (OS).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e6, doi. 10.1016/j.clml.2017.03.011
- By:
- Publication type:
- Article
Overall Survival (OS) and Progression-Free Survival (PFS) Adjusted for Treatment Crossover in the CALGB/ECOG 100104 (Alliance) Study of Lenalidomide (LEN) Versus Placebo (PBO) Maintenance After Stem Cell Transplant (SCT) for Patients With Newly Diagnosed Multiple Myeloma
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e135, doi. 10.1016/j.clml.2017.03.244
- By:
- Publication type:
- Article
Anaplastic Multiple Myeloma: An Aggressive Variant With a Poor Response to Novel Therapies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pleiotropic Effects of a Schweinfurthin on Isoprenoid Homeostasis.
- Published in:
- Lipids, 2011, v. 46, n. 10, p. 907, doi. 10.1007/s11745-011-3572-y
- By:
- Publication type:
- Article
Quantitative Determination of Geranyl Diphosphate Levels in Cultured Human Cells.
- Published in:
- Lipids, 2009, v. 44, n. 11, p. 1055, doi. 10.1007/s11745-009-3355-x
- By:
- Publication type:
- Article
Isoprenoids: Remarkable diversity of form and function.
- Published in:
- Lipids, 2004, v. 39, n. 4, p. 293, doi. 10.1007/s11745-004-1233-3
- By:
- Publication type:
- Article
Quantitative Clinical Pharmacology of CAR T‐Cell Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 1, p. 11, doi. 10.1002/cpt.2631
- By:
- Publication type:
- Article
BIA 10‐2474: Some Lessons are Clear but Important Questions Remain Unanswered.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 343, doi. 10.1002/cpt.2495
- By:
- Publication type:
- Article
The Changing Face of Oncology Research, Drug Development, and Clinical Practice: Toward Patient‐Focused Precision Therapeutics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 3, p. 399, doi. 10.1002/cpt.1979
- By:
- Publication type:
- Article
Oncology Treatment in the Era of COVID‐19: We Cannot Afford to Hit the Pause Button.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 3, p. 422, doi. 10.1002/cpt.1920
- By:
- Publication type:
- Article
CAR T‐Cell Therapy in Hematologic Malignancies: A Voyage in Progress.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 1, p. 112, doi. 10.1002/cpt.1674
- By:
- Publication type:
- Article
Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies.
- Published in:
- 2007
- By:
- Publication type:
- Correction Notice
Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 2, p. 155, doi. 10.1007/s00280-005-0013-8
- By:
- Publication type:
- Article
A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0273-x
- By:
- Publication type:
- Article
Ophthalmic symptoms, clinical signs and diagnostic delay in infants diagnosed with brain tumours in Denmark between 2007 and 2017.
- Published in:
- Acta Ophthalmologica (1755375X), 2024, v. 102, n. 3, p. 334, doi. 10.1111/aos.15745
- By:
- Publication type:
- Article
Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
- Published in:
- Acta Ophthalmologica (1755375X), 2018, v. 96, n. 7, p. e768, doi. 10.1111/aos.13667
- By:
- Publication type:
- Article
Tumours of the lacrimal gland. Epidemiological, Clinical and Genetic Characteristics.
- Published in:
- Acta Ophthalmologica (1755375X), 2013, v. 91, p. 1, doi. 10.1111/aos.12271
- By:
- Publication type:
- Article
Lacrimal gland lesions in Denmark between 1974 and 2007.
- Published in:
- Acta Ophthalmologica (1755375X), 2013, v. 91, n. 4, p. 349, doi. 10.1111/j.1755-3768.2012.02403.x
- By:
- Publication type:
- Article
Epithelial tumours of the lacrimal gland: a clinical, histopathological, surgical and oncological survey.
- Published in:
- Acta Ophthalmologica (1755375X), 2013, v. 91, n. 3, p. 195, doi. 10.1111/j.1755-3768.2012.02402.x
- By:
- Publication type:
- Article
Granular cell tumour of the lacrimal gland.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Should Overall Survival Remain an Endpoint for Multiple Myeloma Trials?
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 1, p. 31, doi. 10.1007/s11899-019-0495-9
- By:
- Publication type:
- Article
Determination of Minimal Residual Disease in Multiple Myeloma: Does It Matter?
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 1, p. 39, doi. 10.1007/s11899-019-0497-7
- By:
- Publication type:
- Article
Patient‐ and parent‐reported diagnostic delay in children with central nervous system tumors in Denmark.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 8, p. 1, doi. 10.1002/pbc.31128
- By:
- Publication type:
- Article
Investigation of the activity of a novel tropolone in osteosarcoma.
- Published in:
- Drug Development Research, 2024, v. 85, n. 1, p. 1, doi. 10.1002/ddr.22129
- By:
- Publication type:
- Article
Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma.
- Published in:
- Drug Development Research, 2023, v. 84, n. 1, p. 62, doi. 10.1002/ddr.22012
- By:
- Publication type:
- Article